MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

被引：0
|
作者：
Florence Pache
Hanna Zimmermann
Janine Mikolajczak
Sophie Schumacher
Anna Lacheta
Frederike C. Oertel
Judith Bellmann-Strobl
Sven Jarius
Brigitte Wildemann
Markus Reindl
Amy Waldman
Kerstin Soelberg
Nasrin Asgari
Marius Ringelstein
Orhan Aktas
Nikolai Gross
Mathias Buttmann
Thomas Ach
Klemens Ruprecht
Friedemann Paul
Alexander U. Brandt
机构：
[1] Charité – Universitätsmedizin Berlin,NeuroCure Clinical Research Center (NCRC)
[2] Charité – Universitätsmedizin Berlin,Department of Neurology
[3] University of Heidelberg,Molecular Neuroimmunology Group, Department of Neurology
[4] Medical University of Innsbruck,Clinical Department of Neurology
[5] Children’s Hospital of Philadelphia,Division of Neurology
[6] Vejle Hospital,Department of Neurology
[7] University of Southern Denmark,Department of Neurobiology, Institute of Molecular Medicine
[8] Heinrich Heine University,Department of Neurology, Medical Faculty
[9] University of Freiburg,Department of Ophthalmology, Medical Faculty
[10] University of Würzburg,Department of Neurology
[11] University of Würzburg,Department of Ophthalmology
[12] Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin,Experimental and Clinical Research Center
来源：
Journal of Neuroinflammation | / 13卷
关键词：
Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG); aquaporin-4 antibodies (AQP4-IgG); NMO-IgG; neuromyelitis optica; Devic syndrome; neuromyelitis optica spectrum disorders (NMOSD); optic neuritis; optical coherence tomography; visual evoked potentials; visual acuity; retinal neuro-axonal damage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 37 条
  • [21] The Mayo Clinic Glial Autoimmunity Study: AQP4/MOG-IgG serostatus and outcomes in 228 patients presenting with recurrent optic neuritis
    Jitprapaikulsan, Jiraporn
    Chen, John
    Fryer, James
    Weinshenker, Brian
    McKeon, Andrew
    Lennon, Vanda
    Leavitt, Jacqueline
    Flanagan, Eoin P.
    Tobin, W. Oliver
    Chiriboga, A. Sebastian Lopez
    Keegan, B. Mark
    Lucchinetti, Claudia
    Kantarci, Orhun
    Sagen, Jessica
    Pittock, Sean
    NEUROLOGY, 2018, 90
  • [22] MOG-IgG is associated with better visual outcomes after optic neuritis than AQP4-IgG seropositivity, despite similar severity of inner retinal layer thinning
    Sotirchos, Elias
    Filippatou, Angeliki
    Salama, Sara
    Pardo, Santiago
    Mealy, Maureen
    Fitzgerald, Kathryn
    Murphy, Olwen
    Ogbuokiri, Esther
    Prince, Jerry
    Levy, Michael
    Calabresi, Peter
    Saidha, Shiv
    NEUROLOGY, 2019, 92 (15)
  • [23] Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study
    Wang, Junqing
    Tian, Yuan
    Shao, Yi
    Feng, Hui
    Qin, Limin
    Xu, Weiwei
    Liu, Hongjuan
    Xu, Quangang
    Wei, Shihui
    Ma, Lin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2669 - 2679
  • [24] MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
    Jarius, Sven
    Ruprecht, Klemens
    Kleiter, Ingo
    Borisow, Nadja
    Asgari, Nasrin
    Pitarokoili, Kalliopi
    Pache, Florence
    Stich, Oliver
    Beume, Lena-Alexandra
    Huemmert, Martin W.
    Ringelstein, Marius
    Trebst, Corinna
    Winkelmann, Alexander
    Schwarz, Alexander
    Buttmann, Mathias
    Zimmermann, Hanna
    Kuchling, Joseph
    Franciotta, Diego
    Capobianco, Marco
    Siebert, Eberhard
    Lukas, Carsten
    Korporal-Kuhnke, Mirjam
    Haas, Juergen
    Fechner, Kai
    Brandt, Alexander U.
    Schanda, Kathrin
    Aktas, Orhan
    Paul, Friedemann
    Reindl, Markus
    Wildemann, Brigitte
    JOURNAL OF NEUROINFLAMMATION, 2016, 13
  • [25] MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
    Sven Jarius
    Klemens Ruprecht
    Ingo Kleiter
    Nadja Borisow
    Nasrin Asgari
    Kalliopi Pitarokoili
    Florence Pache
    Oliver Stich
    Lena-Alexandra Beume
    Martin W. Hümmert
    Marius Ringelstein
    Corinna Trebst
    Alexander Winkelmann
    Alexander Schwarz
    Mathias Buttmann
    Hanna Zimmermann
    Joseph Kuchling
    Diego Franciotta
    Marco Capobianco
    Eberhard Siebert
    Carsten Lukas
    Mirjam Korporal-Kuhnke
    Jürgen Haas
    Kai Fechner
    Alexander U. Brandt
    Kathrin Schanda
    Orhan Aktas
    Friedemann Paul
    Markus Reindl
    Brigitte Wildemann
    Journal of Neuroinflammation, 13
  • [26] MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison
    Narongkhananukul, Chanomporn
    Padungkiatsagul, Tanyatuth
    Jindahra, Panitha
    Khongkhatithum, Chaiyos
    Thampratankul, Lunliya
    Vanikieti, Kavin
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 4079 - 4088
  • [27] Different Features between Pediatric-Onset and Adult-Onset Patients Who Are Seropositive For MOG-IgG: A Multicenter Study in South China
    Chen, Lu
    Chen, Chen
    Zhong, Xiaonan
    Sun, Xiaobo
    Zhu, Haixia
    Li, Xiaojing
    Yang, Hui
    Shu, Yaqing
    Chang, Yanyu
    Hu, Xueqiang
    Lu, Zhengqi
    Peng, Lisheng
    Qiu, Wei
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 405 - 405
  • [28] Different features between pediatric-onset and adult-onset patients who are seropositive for MOG-IgG: A multicenter study in South China
    Chen, Lu
    Chen, Chen
    Zhong, Xiaonan
    Sun, Xiaobo
    Zhu, Haixia
    Li, Xiaojing
    Yang, Hui
    Shu, Yaqing
    Chang, Yanyu
    Hu, Xueqiang
    Lu, Zhengqi
    Peng, Lisheng
    Qiu, Wei
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 321 : 83 - 91
  • [29] Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series
    Abboud, Hesham
    Steingo, Brian
    Vargas, Diana
    Patel, Julie
    Nealon, Nancy
    Willis, Mary Alissa
    Mao-Draayer, Yang
    Khaitov, Dmitry
    Tsai, Michelle
    Kim, Angie
    Pandey, Krupa
    Levy, Michael
    Molazadeh, Negar
    Romero, Rebecca S.
    Ferayorni, Lisa
    Gholizadeh, Shervin
    JOURNAL OF NEUROIMMUNOLOGY, 2025, 403
  • [30] Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
    Gao, Chenyang
    Zhuo, Zhizheng
    Duan, Yunyun
    Yao, Yajun
    Su, Lei
    Zhang, Xinghu
    Song, Tian
    FRONTIERS IN NEUROLOGY, 2021, 12
1234